✦ LIBER ✦

Chronic Renal Insufficiency and Risk of Early Mortality in Patients Undergoing Carotid Endarterectomy

✍ Scribed by Erik Debing; Pierre Van den Brande

Publisher: Springer
Year: 2006
Tongue: English
Weight: 154 KB
Volume: 20
Category: Article
ISSN: 0890-5096
DOI: 10.1007/s10016-006-9080-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is Carotid Endarterectomy Justified in P

Is Carotid Endarterectomy Justified in Patients with Severe Chronic Renal Insufficiency?

✍ Edward E. Rigdon; Navid Monajjem; Robert S. Rhodes 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 58 KB

Carotid Endarterectomy in Symptomatic an

Carotid Endarterectomy in Symptomatic and Asymptomatic Patients Aged 75 Years or More: Perioperative Mortality and Stroke Risk Rates

✍ Enzo Ballotta; Giuseppe Da Giau; Marina Saladini; Elvira Abbruzzese 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 136 KB

Prospective Randomized Study on Asymptom

Prospective Randomized Study on Asymptomatic Severe Carotid Stenosis and Perioperative Stroke Risk in Patients Undergoing Major Vascular Surgery: Prophylactic or Deferred Carotid Endarterectomy?

✍ Enzo Ballotta; Laura Renon; Giuseppe Da Giau; Bruno Barbon; Aldo De Rossi; Claud 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 75 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency—Preliminary evaluation

✍ D. Craig Brater; David R. Rudy; James R. Voelker; Paula K. Greene; Todd Gehr; Do 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 433 KB

Oral pharmacokinetics of pirenzepine in

Oral pharmacokinetics of pirenzepine in patients with chronic renal insufficiency, failure, and maintenance haemodialysis

✍ T. MacGregor; K. Matzek; J. Keirns; M. Vinocur; A. Chonko 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 215 KB

The pharmacokinetic properties of pirenzepine following administration of a single, 50 mg oral dose were evaluated in three groups of subjects: group I, end stage renal disease requiring maintenance haemodialysis (CLCR 0 to 10 ml.min-1); group II, moderate renal insufficiency (CLCR 10 to 30 ml.min-1

Prevalence of heparin-induced antibodies

Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis

✍ Iván Palomo; Jaime Pereira; Marcelo Alarcón; Gonzalo Díaz; Patricia Hidalgo; Isa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Heparin-induced thrombocytopenia (HIT) type II is a serious complication of heparin therapy. It presents initially as thrombocytopenia, and is associated with thrombosis in 20-50% of the cases. HIT is related to the presence of heparin-induced antibodies (HIA), which show specificity for the PF4hepa